HCW Biologics (HCWB US)

Analysis

Health Care • United States

HCW Biologics Inc. operates as a biopharmaceutical company. The Company focuses on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. HCW Biologics serves customers worldwide.

Refresh

Exchange Announcement • 03 Oct 2026 04:30

S-1 | IPO Registration

Exchange Announcement • 24 Sep 2026 20:30

Current Report (Form 8-K | Period ending 2026-09-23)

Exchange Announcement • 08 Sep 2026 21:00

Current Report (Form 8-K | Period ending 2026-09-04)

Exchange Announcement • 29 Aug 2026 04:42

S-1/A | IPO Registration (Amendment)

Exchange Announcement • 21 Aug 2026 02:58

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00